The treatment success rate for MDR-TB patients in projects approved by the Green Light Committee (GLC) was over 60%, and was higher than in non-GLC projects.

在绿灯委员会批准的项目中耐多药结核患者的治疗成功率超过60%，并且高于非绿灯委员会项目中的成功率。